Biotech giant Gilead Sciences, Inc. GILD has put up a steady performance in 2024 amid a volatile market. Its shares have ...

The purchases were made Tuesday through Thursday. The Occidental Petroleum buy was the first since June, suggesting Berkshire ...

H.C. Wainwright lowered the firm’s price target on Prothena (PRTA) to $48 from $84 and keeps a Buy rating on the shares after the Phase 2b ...